Borviz 2 mg Injection is an anticancer medication containing bortezomib. It is used to treat adults with multiple myeloma (bone marrow cancer) and mantle-cell lymphoma (a type of lymph node cancer). It acts as a proteasome inhibitor, blocking the growth, multiplication, and survival of cancer cells, often by inducing programmed cell death.